N-[4-(1H-pyrazol-3-yl)phenyl]acetamide
Structure Info
- Chemspace ID
- CSSB00011233788 (In-Stock Building Blocks)
- CAS
- 197093-26-8
- MFCD
- MFCD09028475, MFCD09860589, MFCD09028475
- IUPAC Name
- N-[4-(1H-pyrazol-3-yl)phenyl]acetamide
- Mol formula
- C11H11N3O
- Mol weight
- 201 Da
- Catalog Number(s)
- AGN-PC-0O6OKJ, ArZ-UP195110, BBLS00011233788, BBV-32474500, BBV-93316362, BD01217597, CS-0256557, CSC011233788, CSC035194779, CSCR00001527141, EN300-6497023, F668920, FCH7394547, HY-W193841, OR183452, PB383396412, TX01WA43, XHA09326, Y3529447, Z3245052908, Z383318944, ZX-NM238385, a1_266440_125584, bbls00011233788, s_527_1742244_156031, s_527____1742244____156031
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.55
- Heavy atoms count
- 15
- Rotatable bond count
- 2
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.09
- Polar surface area (Å)
- 58
- Hydrogen bond acceptors count
- 2
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSSB00011233788
Items Overall 5 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 26.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 36.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 53.00 | |
| Fluorochem | 12 days | Ireland To: | 98 | 250 mg | 180.00 | |
| Fluorochem | 12 days | Ireland To: | 98 | 500 mg | 269.00 | |
Description: n-[4-(1h-pyrazol-3-yl)phenyl]acetamide; ; Storage Conditions: ambient storage; Hazard Codes: H302, H315, H319, H335; GHS Pictograms: GHS07; CAS: 197093-26-8 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of N-[4-(1H-pyrazol-3-yl)phenyl]propanamide - CSSB00000317890](/st/structure/200/6938edb3f9a44275ee5a00d3d676ee32/CCC%2528%253DO%2529NC1%253DCC%253DC%2528C%253DC1%2529C1%253DNNC%253DC1.png)
![Chemical structure of N-[4-(5-amino-1H-pyrazol-3-yl)phenyl]acetamide - CSSB00009996706](/st/structure/200/c1814f36ae8e2109a637824490ba835d/CC%2528%253DO%2529NC1%253DCC%253DC%2528C%253DC1%2529C1%253DNNC%2528N%2529%253DC1.png)
![Chemical structure of N-[4-(1H-pyrazol-3-yl)phenyl]butanamide - CSSB00000524897](/st/structure/200/957e913c6aef8d2436bc43c5266c6e4c/CCCC%2528%253DO%2529NC1%253DCC%253DC%2528C%253DC1%2529C1%253DNNC%253DC1.png)
![Chemical structure of N-[4-(1H-pyrazol-3-yl)phenyl]cyclopropanecarboxamide - CSSB00000654787](/st/structure/200/98ec4ceabb172e565bb3991f2051cc2e/O%253DC%2528NC1%253DCC%253DC%2528C%253DC1%2529C1%253DNNC%253DC1%2529C1CC1.png)
![Chemical structure of 2-methyl-N-[4-(1H-pyrazol-3-yl)phenyl]propanamide - CSSB00000654835](/st/structure/200/3716e2b349cd8cb5fd95f2b02142e174/CC%2528C%2529C%2528%253DO%2529NC1%253DCC%253DC%2528C%253DC1%2529C1%253DNNC%253DC1.png)
![Chemical structure of 3-methyl-N-[4-(1H-pyrazol-3-yl)phenyl]butanamide - CSSB00000412592](/st/structure/200/5784fbfe585e970b3ec708f51a11bba7/CC%2528C%2529CC%2528%253DO%2529NC1%253DCC%253DC%2528C%253DC1%2529C1%253DNNC%253DC1.png)
![Chemical structure of 2,2-dimethyl-N-[4-(1H-pyrazol-3-yl)phenyl]propanamide - CSSB00000675076](/st/structure/200/90981da83bb27559b609566bdb829d5a/CC%2528C%2529%2528C%2529C%2528%253DO%2529NC1%253DCC%253DC%2528C%253DC1%2529C1%253DNNC%253DC1.png)

![Chemical structure of N-[4-(1H-pyrazol-3-yl)phenyl]formamide - CSSB00011725799](/st/structure/200/e15a1916d674868574b463e5fcd112f7/O%253DCNC1%253DCC%253DC%2528C%253DC1%2529C1%253DNNC%253DC1.png)
![Chemical structure of N-[4-hydroxy-3-(1H-pyrazol-3-yl)phenyl]acetamide - CSSB00010232147](/st/structure/200/1d9fcd5c363547296816c1fd2a1581f8/CC%2528%253DO%2529NC1%253DCC%253DC%2528O%2529C%2528%253DC1%2529C1%253DNNC%253DC1.png)
![Chemical structure of 1-[4-(1H-pyrazol-3-yl)phenyl]ethan-1-one - CSSB00102676655](/st/structure/200/1957991c94391fb292856ad3dafbe1a1/CC%2528%253DO%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNNC%253DC1.png)
